Pharmaceuticals Financial News

Dr. Reddy's Laboratories Ltd.(up 2.5 per cent), Glenmark Pharmaceuticals Ltd.(up 1.4 per cent), Sun Pharmaceutical Industries Ltd.(up 1.37 per cent), Torrent Pharmaceuticals Ltd.(up 1.36 per cent) and Divi's Laboratories Ltd.(up 1.06 per cent) were among the top gainers.

Don’t be surprised if you’re stuck behind a chocolate lab, a Scottish fold and a guinea pig when you’re picking up cold medication at the pharmacy in the years ahead.

Congress MP Manickam Tagore has written to Prime Minister Narendra Modi, expressing concern over the National Pharmaceutical Pricing Authority's recent decision to increase prices of eight commonly-used drugs and sought the establishment of an independent review committee to assess the real impact of the price hike. In the letter, Tagore said he was writing to express his concern regarding the recent decision by the National Pharmaceutical Pricing Authority (NPPA) to increase the ceiling prices of eight commonly-used drugs by 50 per cent. «While I understand that the government cited 'extraordinary circumstances' and 'public interest' as reasons for this increase, I believe it is crucial to clarify the rationale behind such a significant decision,» the Congress MP from Tamil Nadu's Virudhunagar said. «This price hike affects vital medications for conditions like asthma, tuberculosis, bipolar disorder, and glaucoma, which are essential for millions of citizens,» Tagore said.

Indian indices have fallen 7-8% in the last month, wherein US indices have inched up 1-2% and the rest of world, including China, being stable. This could be due to two reasons a) The Chinese stimulus package announced in September to revise their real estate and stock markets b) Weaker than expected earnings results for India Inc. in Q2F2025 so far. FII outflow at over US$ 10 billion has been unprecedented, probably moving into China. The India Earnings growth story has been delayed but not derailed and it is just a matter of time. The themes we would like to be invested in the current environment are largely domestic facing sectors like the capex-related power sector against global, especially since we are having strong economic tailwinds and global headwinds for slowdown in growth. In the global facing sector, we would like to be invested in India’s outsourcing stories like pharmaceuticals.

The European Commission has fined Israeli generic drugmaker Teva more than 460 million euros ($500 million) for improperly seeking to protect the patent for its multiple sclerosis drug and for disparaging a rival company’s development of a competing me...

Eli Lilly is dialing back its 2024 forecast after underwhelming Wall Street with third-quarter earnings and sales from two key drugs that missed expectations

Shares of Mankind Pharma Ltd.(up 3.92 per cent), Natco Pharma Ltd.(up 3.1 per cent), Sanofi India Ltd.(up 2.1 per cent), J B Chemicals & Pharmaceuticals Ltd.(up 1.54 per cent) and Divi's Laboratories Ltd.(up 1.44 per cent) ended the day as top gainers in the pack.

buy call on Sun Pharma with a target price of Rs 2,280. The current market price of Sun Pharma is Rs 1869.85 .Sun Pharmaceutical Industries, incorporated in 1993, is a Large Cap company with a market cap of Rs 450271.20 crore, operating in pharmaceuticals sector. Sun Pharmaceutical Industries' key products/revenue segments include pharmaceuticals and other operating revenue for the year ending 31-Mar-2024.

Laurus Labs Ltd.(up 3.83 per cent), Biocon Ltd.(up 2.54 per cent), Natco Pharma Ltd.(up 1.98 per cent), Granules India Ltd.(up 1.86 per cent) and Glenmark Pharmaceuticals Ltd.(up 1.76 per cent) were among the top gainers.

Shreya Life Sciences from the many other commercial businesses that keep the Andheri neighborhood of India’s largest metropolis humming throughout the day. But this inconspicuous pharmaceutical company is part of a lucrative trade in leading-edge technology to Russia that has the US and its European allies worried at India’s burgeoning role as an intermediary in the sales. A Bloomberg News analysis of data compiled by trade-tracking firms ImportGenius and NBD shows that Shreya exported 1,111 units of Dell Technologies Inc.’s most-advanced servers to Russia in April-August of this year.

A scientific panel is recommending that people 50 and older get a shot against bacteria that can cause pneumonia and other dangerous illnesses

The NSE Nifty index closed 36.6 points down at 24435.5, while BSE Sensex ended down 138.74 points at 80081.98.

Sampath Reddy, Founder & CIO, Azurean Investment Managers, says overall, the steep growth in the earnings that we had seen in the last several quarters, is getting decelerated. As a result, overall the valuation premium that we used to enjoy vis-a-vis most other global markets is getting slightly compressed. So, we could see a subdued trend in the market for some more time, more so in the midcap and smallcap segments. I am guessing the portfolio is not looking a very pretty picture right now and if possible, perhaps one should stay away from looking at the portfolios today with the kind of weakness that we are seeing. But do you expect this to be only a transient issue or are the next couple of weeks and months going to be full of turmoil and volatility for individual investors? Sampath Reddy: The way the markets have moved up over the last few years, overall valuations are on the higher side, especially more so in the midcap and smallcap segment where the valuations are much more steep. Because of which, there could be a subduedness in the market overall for the very near term and even if we were to look at the quarterly numbers of the Q2, most other places, the numbers are coming slightly below expectations.

Nirmala Sitharaman, arrived in the United States and received a warm welcome at Newark Liberty International Airport on Sunday (local time). India's Ambassador to the United States, Vinay Mohan Kwatra, and Consul General of India in New York, Binaya Srikanta Pradhan, welcomed Sitharaman, following her arrival from Mexico City. «Union Minister of Finance and Corporate Affairs Smt. @nsitharaman is welcomed at the Newark Liberty International Airport by India's Ambassador to USA, Shri @AmbVMKwatra along with Consul General of India in New York, Shri @binaysrikant76, after her arrival from Mexico City, today,» the Ministry of Finance stated in a post on X.

FAST India) in collaboration with IIFL Securities. The largest disparity was observed in the number of publications per billion USD revenue, with global firms producing 8.4 times more publications than Indian firms, the report noted. Global firms generated 5.6 times more patents and 8.4 times more publications per billion USD of revenue compared to Indian firms.

Subscribe to enjoy similar stories. Private equity investors including Quadria Capital and TPG Capital have expressed initial interest to invest about $100 million for a 20-25% stake in critical care drugs provider Samarth Life Sciences, three people familiar with the matter said. “The transaction is expected to be purely secondary with the promoter group selling some of its stake," one of the people cited above said on the condition of anonymity.

Piyush Goyal recently held a crucial meeting with several prominent stakeholders from the pharmaceutical industry to address concerns of pharmaceutical exporters. The meeting held on Wednesday was attended by the General Secretary of the Indian Drug Manufacturers Association (IMDA), along with several other prominent stakeholders from the pharmaceutical industry. According to a statement by minister's office, the discussions aimed to address the pressing challenges faced by pharmaceutical exporters and explore potential solutions to enhance India's global standing in the sector.

Sagility India and Senores Pharmaceuticals have received approvals from the Securities and Exchange Board of India (Sebi) for their proposed initial public offerings (IPOs). The regulator issued its final observations on the draft papers last week. When a company receives a final observation from Sebi, it’s a signal from the regulator to go ahead with the IPO process. Sagility India’s IPO consists solely of an offer for sale (OFS) of 984.4 million shares by promoter Sagility BV. The company provides technology-driven services to insurance settlement entities and healthcare providers.

J B Chemicals & Pharmaceuticals Ltd.(up 1.96 per cent), Lupin Ltd.(up 0.64 per cent), Abbott India Ltd.(up 0.61 per cent), Biocon Ltd.(up 0.58 per cent) and Ipca Laboratories Ltd.(up 0.42 per cent) were among the top gainers.

vaccine doses manufactured and distributed across the world in the last one year alone, half of them were manufactured in India, said Union Health Secretary Punya Salila Srivastava. She said this while addressing the annual India Leadership Summit 2024, organised by the US-India Strategic Partnership Forum here today. Punya said India has emerged as a global leader in pharmaceuticals, being the third-largest producer and a key supplier of generic medicines. This sector's success has resulted in substantial savings for healthcare systems worldwide, including a notable contribution to the US healthcare system.

Subscribe to enjoy similar stories. When former executives team up with an activist investor to “help" a struggling company, it is often bad news for the current chief executive. That is one implication behind activist investor Starboard Value’s $1 billion stake and its push to make changes at Pfizer, which The Wall Street Journal reported has support from former Pfizer Chief Executive Ian Read and former Chief Financial Officer Frank D’Amelio.